Our Company

더 나은 삶을 위한 재생분야 전문기업

(주)가이스트리히 코리아를 방문해 주셔서 감사합니다.

(주)가이스트리히 코리아는 스위스에 위치한 치과재생재료분야의 세계적 선두기업인 Geistlich Pharma AG의 한국지사로 국내에 치과용 골 이식 재료와 차폐 막 재료를 공급하고 있습니다.

저희 제품을 사용하시는 모든 고객들과 환자들에게 보다 더 나은 제품과 삶의 질을 주고자 최선을 다하고 있습니다.

향후 더욱 발전된 모습으로 국민 건강에 크게 기여할 수 있는 기업이 될 것을 약속 드립니다.

We are an internationally active Swiss MedTech company that is a world leader in the field of natural and rapid regeneration of bone, cartilage and tissue. As part of the Geistlich Group, we develop, produce and distribute a wide range of products for regenerative medicine.

At Geistlich, we envision a future in which patients' tissue is no longer replaced but regenerated. As a manufacturer of biomaterials, we offer a diverse range of products that are used in areas such as dentistry, sports medicine, cartilage and wound healing. Our core competence is the development and production of products that promote the body's own regeneration processes.

Our portfolio includes the bone replacement material Geistlich Bio-Oss® for bone regeneration and the collagen membrane Geistlich Bio-Gide®. With both products, Dr. Peter Geistlich laid the foundation for the field of medical regeneration in the 1980s. Today, a Geistlich product is used every 14 seconds, making Geistlich the global market leader in the field of regenerative dentistry.

Together with our international network of medical specialists, we do everything we can to achieve the highest possible quality of life for patients.

Geistlich has been producing products of the highest quality in Wolhusen since 1899. We have two sites in central Switzerland. We have 15 affiliates in various countries in order to serve the global market and maintain close contact with our customers. In addition to these locations, we have a large number of distributors worldwide. The interactive map shows all locations, distribution partners and affiliates of the Swiss MedTech company Geistlich.

Geistlich's management consists of the Executive Leadership Team and the Board of Directors. Both stand for medical progress, innovative research and family values.

• Dr. Andreas Geistlich, Chairman of the Board of Directors
• Jakob Hirzel
• Dr. Martin Geistlich
• Prof. Dr. Simon P. Hoerstrup
• Prof. Dr. Christoph B. Bühler
• Roger Baillod
• Dr. Felix Reiff